For instance, a study presented at the American College of Gastroenterologys Annual Scientific Meeting noted that patients with a history of type 2 diabetes, tobacco use, and advanced chronic kidney disease were at a higher risk for developing acute pancreatitis after starting GLP-1 therapy
Excess aldosterone, in addition to increasing tubular sodium reabsorption, activates inflammatory and pro-fibrotic pathways and promotes vascular remodelling [15]
Manufacturers Amgen, AstraZeneca and Structure Therapeutics, among others, have anti-obesity drugs in the pipeline
Breaks make sense for users experiencing treatment plateau where benefits cease increasing despite continued application suggesting diminishing returns from ongoing use, comfortable with some benefit decline during off periods accepting fluctuation in skin quality, budget-conscious seeking to minimize annual treatment costs through intermittent purchasing, philosophically preferring avoiding indefinite dependency on any skincare product, planning life changes incompatible with consistent application (extended travel, relocation, financial shifts), and wanting to assess whether improvements prove durable or require continuous maintenance before committing to indefinite treatment